Literature DB >> 8084503

Two types of dystrophic neurites in senile plaques of Alzheimer disease and elderly non-demented cases.

O Yasuhara1, T Kawamata, Y Aimi, E G McGeer, P L McGeer.   

Abstract

Senile plaques (SPs) occur profusely in brain tissue of Alzheimer disease (AD) cases, and sparsely in brain tissue of elderly normals. Two types of dystrophic neurites (DNs) have been identified in SPs. Type 1 are the classically described elongated forms. Type 2 are globular in shape. Type 1 DNs are stained immunohistochemically by antibodies to A68 protein, other forms of phosphorylated tau, and N-terminal epitopes of amyloid precursor protein (APP), as well as an antibody which preferentially recognized conjugated ubiquitin. Type 2 DNs are stained immunohistochemically by antibodies to chromogranin A and C-terminal epitopes of APP, as well as an antibody which preferentially recognizes free ubiquitin. SPs of AD cases usually contain a mixture of type 1 and type 2 DNs. However, in the neocortex of elderly normals, which have few neurofibrillary tangles and neuropil threads, the DNs in the SPs are restricted to type 2. These data suggest that SPs containing only type 2 DNs may be benign, and independent of neurofibrillary pathology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8084503     DOI: 10.1016/0304-3940(94)90608-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  C-terminal fragments of amyloid-beta peptide cause cholinergic axonal degeneration by a toxic effect rather than by physical injury in the nondemented human brain.

Authors:  Peter Kasa; Henrietta Papp; Janos Zombori; Peter Mayer; Frederic Checler
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 2.  Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.

Authors:  C Glabe
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

3.  A History of Senile Plaques: From Alzheimer to Amyloid Imaging.

Authors:  Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2022-05-20       Impact factor: 3.148

4.  Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons.

Authors:  O Yasuhara; A Matsuo; I Tooyama; H Kimura; E G McGeer; P L McGeer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 5.  Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.

Authors:  Prashant R Bharadwaj; Ashok K Dubey; Colin L Masters; Ralph N Martins; Ian G Macreadie
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

Review 6.  Defining the earliest pathological changes of Alzheimer's disease.

Authors:  James C Vickers; Stan Mitew; Adele Woodhouse; Carmen M Fernandez-Martos; Mathew T Kirkcaldie; Alison J Canty; Graeme H McCormack; Anna E King
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 7.  The neuropathological diagnosis of Alzheimer's disease.

Authors:  Michael A DeTure; Dennis W Dickson
Journal:  Mol Neurodegener       Date:  2019-08-02       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.